LGC Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LGC Limited - overview
Established
1842
Location
-, Middlesex, UK
Primary Industry
Biotechnology
About
Based in Middlesex, UK and founded in 1842, LGC Science Group Holdings Limited is a biotechnology and life science company that focuses on providing laboratory services including genomics reagents and instrumentation, drug development and technology platforms to the healthcare sector. The company, previously known as The Laboratory of the Government Chemist, was privatised and renamed LGC in 1996, and is nowadays owned by Cinven, Astorg and ADIA affiliated funds. LGC Science Group is also the UK National Measurement Laboratory and Designated Institute for chemical and bio-measurement. As of June 2021, the company has 4,350 employees.
The products of LGC Science Group Holdings Limited can be categorised into four main areas: firstly, quality assurance solutions such as proficiency testing, clinical diagnostics, supply chain assurance, and sports and specialised analytical services; secondly, genomic analysis tools including molecular biology reagents and services, reagents and instruments of oligo synthesis; thirdly, drug development solutions which include bioanalytical sciences, and analytical and material sciences; lastly, national laboratory services such as health research programme management and UK National Measurement Laboratory Chemical and bio-measurement services. The above-mentioned solutions are primarily designed for industries of healthcare, applied markets such as food, seed producers and aquaculture, as well as research institutes and the government.
Current Investors
Cinven, Astorg, Abu Dhabi Investment Authority
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories, Medical Equipment Distributors, Pharmaceutical Research & Development
Website
www.lgcgroup.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
LGC Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out, Trade Sale | Completed | Ideagen Safefood 360° | - | ||||||||
| Add-on, Trade Sale | Completed | Kova International Inc | - | ||||||||
| Add-on, Corporate Carve Out, Trade Sale | Completed | Resolian | - | ||||||||
| Add-on | Completed | Ideagen Safefood 360° | - | ||||||||
| Add-on, Trade Sale | Completed | The Native Antigen Company Ltd. | - |
Displaying 1 - 5 of 25

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.